A 600,000-Person Study Says Ozempic Prevents Addiction
Veterans on GLP-1 drugs had lower rates of every major substance use disorder — alcohol, opioids, nicotine, cocaine, cannabis.
Nora Whitfield
Bureau: Chicago
The Wegovy Pill Reached 400,000 Americans
Roughly 400,000 Americans are taking the oral Wegovy pill just ten weeks after its January launch.
Stopping Ozempic Raises Cardiovascular Risk by 22 Percent
A study of 330,000 patients found that quitting GLP-1 drugs for two years raised cardiovascular risk by 22 percent.
GLP-1 Drugs May Also Treat Substance Use Disorders
A BMJ study of 600,000 veterans found GLP-1 drugs associated with reduced risk of substance use disorders and overdose.
The FDA Warned 30 Telehealth Companies About Compounded GLP-1s
The FDA sent warning letters to 30 telehealth companies for false and misleading marketing of compounded GLP-1 drugs.
Neurowellness Became the Wellness Industry's New Frontier
Neurowellness, the focus on brain health through neurotech devices and mental fitness routines, emerged as the dominant wellness trend of 2026.